MedDataX Logo

Efficiency of Shock-wave Therapy in Symptomatic Hip Osteoarthritis

NCT ID: NCT04206722

Last Updated: 2019-12-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-06-30

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objectives of treatment in hip osteoarthritis are pain relief, improve joint range of motion and muscle force, gait rehabilitation, patient education and socio-professional reintegration.The non-pharmacological and non-surgical methods include certain types of physical therapy: massage, heat, ultrasound, laser, shockwave therapy. Few studies have been conducted so far for outcome measurement in symptomatic hip osteoarthritis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objectives of treatment in hip osteoarthritis are pain relief, improve joint range of motion and muscle force, gait rehabilitation, patient education and socio-professional reintegration.The non-pharmacological and non-surgical methods include certain types of physical therapy: massage, heat, ultrasound, laser, shockwave therapy. Among them, shockwave therapy is not a new treatment method, and seems to be effective in rotator cuff pathology, tennis elbow, and also on knee osteoarthritis, but few studies have been conducted so far for outcome measurement in symptomatic hip osteoarthritis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment group

Shock Wave therapy on the affected hip, for 10 days, 1 application every 2 days

Group Type EXPERIMENTAL

Shock Wave Therapy

Intervention Type DEVICE

Shock Wave therapy - hip osteoarthritis program

Control group

Ultrasound therapy on the affected hip, for 10 days, 1 application daily

Group Type ACTIVE_COMPARATOR

Ultrasound

Intervention Type DEVICE

Ultrasound 0.7W/cm2

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Shock Wave Therapy

Shock Wave therapy - hip osteoarthritis program

Intervention Type DEVICE

Ultrasound

Ultrasound 0.7W/cm2

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* unilateral or bilateral hip osteoarthritis

Exclusion Criteria

* other disorders that are contraindications for shockwave or ultrasound application
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Iuliu Hatieganu University of Medicine and Pharmacy

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ciubean Alina Deniza

Principal investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Irsay Laszlo, MD, PhD

Role: STUDY_DIRECTOR

University of Medicine and Pharmacy Iuliu Hatieganu

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UniversitateaMFHIL

Identifier Type: -

Identifier Source: org_study_id